Kempopeptin C, a Novel Marine-Derived Serine Protease Inhibitor Targeting Invasive Breast Cancer

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma

(2015) Steffen Ormanns et al.   BRITISH JOURNAL OF CANCER

Desmoglein 2 Depletion Leads to Increased Migration and Upregulation of the Chemoattractant Secretoneurin in Melanoma Cells

(2014) Wiebke K. Peitsch et al.   PLoS One

Potent Elastase Inhibitors from Cyanobacteria: Structural Basis and Mechanisms Mediating Cytoprotective and Anti-Inflammatory Effects in Bronchial Epithelial Cells

(2013) Lilibeth A. Salvador et al.   JOURNAL OF MEDICINAL CHEMISTRY

From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion

(2012) Vinita Wadhawan et al.   BIOCHEMICAL JOURNAL

Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms

(2012) M E Law et al.   ONCOGENE

Diversity of Matriptase Expression Level and Function in Breast Cancer

(2012) Arkadiusz Welman et al.   PLoS One

A Novel Signaling Axis of Matriptase/PDGF-D/ -PDGFR in Human Prostate Cancer

(2010) C. V. Ustach et al.   CANCER RESEARCH

Type II Transmembrane Serine Protease (TTSP) deregulation in cancer

(2010) Siobhan et al.   Frontiers in Bioscience-Landmark

Proteolysis-induced N-terminal Ectodomain Shedding of the Integral Membrane Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Is Accompanied by Tyrosine Phosphorylation of Its C-terminal Domain and Recruitment of Src and PKCδ

(2010) Yaowu He et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Multiple Toxin Production in the CyanobacteriumMicrocystis: Isolation of the Toxic Protease Inhibitor Cyanopeptolin 1020

(2010) Karl Gademann et al.   JOURNAL OF NATURAL PRODUCTS

Increased expression of Dsg2 in malignant skin carcinomas

(2010) Donna Brennan et al.   Cell Adhesion & Migration

Matriptase: a culprit in cancer?

(2009) Karin List   Future Oncology

Lyngbyastatins 8–10, Elastase Inhibitors with Cyclic Depsipeptide Scaffolds Isolated from the Marine Cyanobacterium Lyngbya semiplena

(2009) Jason Kwan et al.   Marine Drugs

Functional Role of Cell Surface CUB Domain-Containing Protein 1 in Tumor Cell Dissemination

(2009) E. I. Deryugina et al.   MOLECULAR CANCER RESEARCH

Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer

(2008) Vishnu C Ramani et al.   BMC CANCER

Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung

(2008) Jun-ichiro Ikeda et al.   CANCER SCIENCE

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma

(2008) Yasuo Awakura et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Kempopeptins A and B, Serine Protease Inhibitors with Different Selectivity Profiles from a Marine Cyanobacterium,Lyngbyasp.

(2008) Kanchan Taori et al.   JOURNAL OF NATURAL PRODUCTS

Symplocamide A, a Potent Cytotoxin and Chymotrypsin Inhibitor from the Marine CyanobacteriumSymplocasp.

(2007) Roger G. Linington et al.   JOURNAL OF NATURAL PRODUCTS